A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. - Image: Scott Olson / Staff (Getty Ima...
Modulus Therapeutics Competitors or Alternatives
Modulus Therapeutics's top competitors include Hibercell, Fate Therapeutics and Nkarta.
Modulus Therapeutics VS Hibercell
Hibercell is a top competitor of Modulus Therapeutics. Hibercell is a Private company that was founded in 2018 in New York, Minnesota. Hibercell operates in the Biotechnology industry. Compared to Modulus Therapeutics, Hibercell has 30 more employees.
Modulus Therapeutics VS Fate Therapeutics
Fate Therapeutics is seen as one of Modulus Therapeutics's biggest rivals. Fate Therapeutics was founded in 2007, and is headquartered in San Diego, California. Fate Therapeutics is in the Biotechnology industry. Fate Therapeutics generates $10.4M more revenue vs. Modulus Therapeutics.
Looking for similar companies to Modulus Therapeutics?
Similar Companies
Pharmaceuticals & Biotech Technology companies with employees in 1-25 range
See 111 companies
Pharmaceuticals & Biotechnology companies in SeattleSee 193 companies
Pharmaceuticals & Biotech Technology companies in USASee 171 companies
Pharmaceuticals & Biotech Technology companies in North AmericaSee 177 companies
Pharmaceuticals & Biotech Technology companies with revenue in $100K-5.0M rangeSee 152 companies
Pharmaceuticals & Biotechnology companies in Seattle Metropolitan AreaSee 327 companies
Pharmaceuticals & Biotechnology companies in WashingtonSee 506 companies
Companies in Seattle with employees in 1-25 rangeSee 2,019 companies
Pharmaceuticals & Biotechnology companies with employees in 1-25 rangeSee 4,662 companies
Trending News for Modulus Therapeutics and Modulus Therapeutics's Competitors
The biotech is slashing a third of its workforce and more than half of its executive team in moves it called "necessary in today's challenging financia...
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sana Biotechnology, Inc. ("Sana...
Nkarta, Inc. (NASDAQ:NKTX) reported a fourth-quarter earnings report on Wednesday with a loss of 35 cents per share, beating the consensus of a loss of...
Nkarta’s employee count changed from 150 in Dec 2023 to 157 in Dec 2024 increasing 4.7% in this time period....
The European Medicines Agency committee said the benefits of the new drug, Kisunla, did not outweigh the risks, and it recommended refusing marketing a...
Eli Lilly & Co.'s Alzheimer's disease drug Kisunla failed to get the backing of European regulators, who said its benefits don't outweigh the risk of p...
NEW YORK , March 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Sh...
Beiser worked at the drugmaker since April 2020....
Eli Lilly aims to connect patients with providers to facilitate timely diagnosis of Alzheimer's disease....
Frequently Asked Questions about Modulus Therapeutics
Who are Modulus Therapeutics's top competitors?
Modulus Therapeutics's top 3 competitors are Hibercell, Fate Therapeutics, Nkarta.Who is similar to Modulus Therapeutics?
Hibercell is the most similar to Modulus Therapeutics. Fate Therapeutics and Nkarta are also similar to Modulus Therapeutics.
Are Modulus Therapeutics and Hibercell competitors?
Yes, Hibercell is one of Modulus Therapeutics’s top competitors.